AstraZeneca
Page 2 of 13
SuccessRyanair’s Michael O’Leary, who is up for a $108 million bonus, doesn’t see high CEO pay as a problem: ‘Footballers are getting half a million a week’
By Prarthana PrakashApril 29, 2024
RetailAstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs
By Ashleigh Furlong and BloombergApril 25, 2024
SuccessMajor investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By Ryan HoggApril 10, 2024
FinanceMeet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy
By Ryan HoggMarch 3, 2024
By Sophie MellorOctober 11, 2022
By BloombergAugust 27, 2022
HealthThe most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By Sy Mukherjee and IDEA PharmaApril 20, 2022
HealthNew drug that prevents you from catching COVID-19 gets green light in Europe — but it’s been in the U.S. for months and hardly anyone knows about it
By Sophie MellorMarch 29, 2022
By Jeremy KahnDecember 29, 2021
HealthModerna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
By Jeremy KahnDecember 21, 2021
HealthEU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
Most Popular
